You are currently viewing a new version of our website. To view the old version click .

Pharmaceutics, Volume 10, Issue 3

September 2018 - 91 articles

Cover Story: Surfactant-based permeability enhancers are receiving increasing attention for the enhancement of the bioavailability of biopharmaceutics administered via oral or pulmonary routes. In vitro testing on intestinal Caco-2 and airway epithelial Calu-3 cells highlighted the relationship between the chemical structure of lactose-based fatty acid monoesters and their biological effects on macromolecular drug permeability. Biological studies demonstrated that the application on cells of cytotoxic concentrations above CMC was associated with depolarizing mitochondrial membrane potential, increasing nuclear membrane permeability, and activating effector caspases. Non-cytotoxic concentrations induced a reversible membrane perturbance action, as commonly exerted by surfactants acting as permeability enhancers. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (91)

  • Article
  • Open Access
107 Citations
9,190 Views
13 Pages

Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy

  • Mengen Zhang,
  • Jingyi Zhu,
  • Yun Zheng,
  • Rui Guo,
  • Shige Wang,
  • Serge Mignani,
  • Anne-Marie Caminade,
  • Jean-Pierre Majoral and
  • Xiangyang Shi

We present here the development of multifunctional doxorubicin (DOX)-conjugated poly(amidoamine) (PAMAM) dendrimers as a unique platform for pH-responsive drug release and targeted chemotherapy of cancer cells. In this work, we covalently conjugated...

  • Article
  • Open Access
17 Citations
5,527 Views
18 Pages

Nanocrystals research has been an area of significant interest lately, providing oral bioavailability benefits to solubility- and/or dissolution rate-limited drugs. Drug nanocrystals are generated using top-down or bottom-up technologies. Combination...

  • Article
  • Open Access
51 Citations
7,606 Views
25 Pages

To develop sustained release gastro-retentive effervescent floating tablets (EFT), a quality-based experimental design approach was utilized during the composing of a hydrophilic matrix loaded with a high amount of a highly water-soluble model drug,...

  • Review
  • Open Access
57 Citations
11,227 Views
22 Pages

Developments in Taste-Masking Techniques for Traditional Chinese Medicines

  • Xiao Zheng,
  • Fei Wu,
  • Yanlong Hong,
  • Lan Shen,
  • Xiao Lin and
  • Yi Feng

A variety of pharmacologically active substances, including chemotherapeutic drugs and the substances from traditional Chinese medicine (TCM), always exhibit potent bioactivities after oral administration. However, their unpleasant taste (such as bit...

  • Article
  • Open Access
39 Citations
6,171 Views
22 Pages

Co-administration of conventional and natural chemotherapeutics offers synergistic anticancer efficacy while minimizing adverse effects. In this study, an oral co-delivery system for pemetrexed (PMX) and quercetin (QCN) was designed based on water-in...

  • Review
  • Open Access
276 Citations
18,311 Views
26 Pages

Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview

  • Elena Giuliano,
  • Donatella Paolino,
  • Massimo Fresta and
  • Donato Cosco

Poloxamer 407, also known by the trademark Pluronic® F127, is a water-soluble, non-ionic triblock copolymer that is made up of a hydrophobic residue of polyoxypropylene (POP) between the two hydrophilic units of polyoxyethylene (POE). Poloxamer 4...

  • Article
  • Open Access
19 Citations
6,752 Views
13 Pages

Nanocrystallization and amorphization have proven to be two effective strategies to improve the bioavailability of water-insoluble drugs. The purpose of our work was to develop a nano-formulated tablet of sirolimus (SRL) for enhanced dissolution. Amo...

  • Article
  • Open Access
18 Citations
5,662 Views
15 Pages

Effect on Nail Structure and Transungual Permeability of the Ethanol and Poloxamer Ratio from Cyclodextrin-Soluble Polypseudorotaxanes Based Nail Lacquer

  • Elena Cutrín-Gómez,
  • Soledad Anguiano-Igea,
  • M. Begoña Delgado-Charro,
  • José Luis Gómez-Amoza and
  • Francisco J. Otero-Espinar

Aqueous-based nail lacquers have shown potential in promoting the diffusion of drugs into the nail. In our laboratory, we have recently developed a transungual delivery system based on an aqueous dispersion of cyclodextrin-poloxamer soluble polypseud...

  • Feature Paper
  • Article
  • Open Access
32 Citations
6,191 Views
13 Pages

Synthesis of a Bone-Targeted Bortezomib with In Vivo Anti-Myeloma Effects in Mice

  • Hua Wang,
  • Lifeng Xiao,
  • Jianguo Tao,
  • Venkat Srinivasan,
  • Brendan F. Boyce,
  • Frank H. Ebetino,
  • Babatunde O. Oyajobi,
  • Robert K. Boeckman and
  • Lianping Xing

Multiple myeloma (MM) is the most common cancer affecting the bone and bone marrow and remains incurable for most patients; novel therapies are therefore needed. Bortezomib (Btz) is an FDA-approved drug for the treatment of patients with MM. However,...

  • Article
  • Open Access
30 Citations
7,185 Views
11 Pages

Iontophoretic Transdermal Delivery of Human Growth Hormone (hGH) and the Combination Effect of a New Type Microneedle, Tappy Tok Tok®

  • Gyubin Noh,
  • Taekwang Keum,
  • Jo-Eun Seo,
  • Santosh Bashyal,
  • Nyeon-Sik Eum,
  • Min Jung Kweon,
  • Sooyeun Lee,
  • Dong Hwan Sohn and
  • Sangkil Lee

Transdermal drug administration presents several advantages and it is therefore favorable as an alternative drug delivery route. However, transdermal delivery of biopharmaceutical drugs is made difficult by the skin barrier. Microneedle application a...

of 10

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923Creative Common CC BY license